Nisoxetine (BioDeep_00000181694)

   

human metabolite blood metabolite


代谢物信息卡片


DL-N-Methyl-3-(O-methoxyphenoxy)-N-methyl-3-phenylpropylamine

化学式: C17H21NO2 (271.1572206)
中文名称: 尼索西汀
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CNCCC(C1=CC=CC=C1)OC2=CC=CC=C2OC
InChI: InChI=1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Hubert J Sijben, Wieke M van Oostveen, Peter B R Hartog, Laura Stucchi, Andrea Rossignoli, Giovanna Maresca, Lia Scarabottolo, Adriaan P IJzerman, Laura H Heitman. Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors. Scientific reports. 2021 06; 11(1):12290. doi: 10.1038/s41598-021-91700-7. [PMID: 34112854]
  • Mo Chen, Yan Zhang, Hongqian Wang, Hao Yang, Wen Yin, Saihong Xu, Tao Jiang, Mansi Wang, Feixiang Wu, Weifeng Yu. Inhibition of the norepinephrine transporter rescues vascular hyporeactivity to catecholamine in obstructive jaundice. European journal of pharmacology. 2021 Jun; 900(?):174055. doi: 10.1016/j.ejphar.2021.174055. [PMID: 33775645]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Hiroya Mizutani, Fukumitsu Sakakibara, Eiji Sasaki. TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder. The Journal of pharmacology and experimental therapeutics. 2020 07; 374(1):84-92. doi: 10.1124/jpet.119.264572. [PMID: 32332112]
  • Madeline M Pantoni, Stephanie A Carmack, Leen Hammam, Stephan G Anagnostaras. Dopamine and norepinephrine transporter inhibition for long-term fear memory enhancement. Behavioural brain research. 2020 01; 378(?):112266. doi: 10.1016/j.bbr.2019.112266. [PMID: 31580915]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Paola Devoto, Giovanna Flore, Pierluigi Saba, Simona Scheggi, Giovanna Mulas, Carla Gambarana, Saturnino Spiga, Gian Luigi Gessa. Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex. Progress in neuro-psychopharmacology & biological psychiatry. 2019 03; 90(?):97-103. doi: 10.1016/j.pnpbp.2018.11.015. [PMID: 30472147]
  • Osama Refai, Randy D Blakely. Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone. Neurochemistry international. 2019 02; 123(?):59-68. doi: 10.1016/j.neuint.2018.05.013. [PMID: 29800604]
  • Daniel P Bermingham, J Andrew Hardaway, Chelsea L Snarrenberg, Sarah B Robinson, Oakleigh M Folkes, Greg J Salimando, Hussain Jinnah, Randy D Blakely. Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo. Neurochemistry international. 2016 09; 98(?):122-8. doi: 10.1016/j.neuint.2016.01.008. [PMID: 26850478]
  • Poojan Pyakurel, Eve Privman Champaloux, B Jill Venton. Fast-Scan Cyclic Voltammetry (FSCV) Detection of Endogenous Octopamine in Drosophila melanogaster Ventral Nerve Cord. ACS chemical neuroscience. 2016 08; 7(8):1112-9. doi: 10.1021/acschemneuro.6b00070. [PMID: 27326831]
  • M Julia García-Fuster, Jesús A García-Sevilla. Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration. Psychopharmacology. 2016 Aug; 233(15-16):2955-71. doi: 10.1007/s00213-016-4342-6. [PMID: 27259485]
  • Hilary R Smith, Thomas J R Beveridge, Michael A Nader, Linda J Porrino. Effects of abstinence from chronic cocaine self-administration on nonhuman primate dorsal and ventral noradrenergic bundle terminal field structures. Brain structure & function. 2016 06; 221(5):2703-15. doi: 10.1007/s00429-015-1066-z. [PMID: 26013302]
  • Eve Privman, B Jill Venton. Comparison of dopamine kinetics in the larval Drosophila ventral nerve cord and protocerebrum with improved optogenetic stimulation. Journal of neurochemistry. 2015 Nov; 135(4):695-704. doi: 10.1111/jnc.13286. [PMID: 26296526]
  • Aravind Penmatsa, Kevin H Wang, Eric Gouaux. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine. Nature structural & molecular biology. 2015 Jun; 22(6):506-508. doi: 10.1038/nsmb.3029. [PMID: 25961798]
  • Noriaki Satoh, Yumiko Toyohira, Keita Takahashi, Nobuyuki Yanagihara. Effects of various pharmacological agents on the function of norepinephrine transporter. Journal of UOEH. 2015 Mar; 37(1):33-42. doi: 10.7888/juoeh.37.33. [PMID: 25787100]
  • Minsoo Han, Chiman Song, Nakcheol Jeong, Hoh-Gyu Hahn. Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine. ACS medicinal chemistry letters. 2014 Sep; 5(9):999-1004. doi: 10.1021/ml500187a. [PMID: 25221656]
  • Zeng-liang Jin, Nana Gao, Jian-rui Zhang, Xiao-rong Li, Hong-xia Chen, Jie Xiong, Yun-feng Li, Yu Tang. The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity. Progress in neuro-psychopharmacology & biological psychiatry. 2014 Aug; 53(?):9-14. doi: 10.1016/j.pnpbp.2014.02.013. [PMID: 24614095]
  • Jun Yun, Minsoo Han, Chiman Song, Seung Hoon Cheon, Kihang Choi, Hoh-Gyu Hahn. Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. Bioorganic & medicinal chemistry letters. 2014 Aug; 24(15):3234-7. doi: 10.1016/j.bmcl.2014.06.026. [PMID: 24974340]
  • Timothy Lynagh, Tina S Khamu, Lesley J Bryan-Lluka. Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity. Naunyn-Schmiedeberg's archives of pharmacology. 2014 Jan; 387(1):95-107. doi: 10.1007/s00210-013-0923-7. [PMID: 24081522]
  • Yoshiyuki Kasahara, Yumiko Kubo, Ichiro Sora. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. 2013 Nov; 33(5-6):185-9. doi: NULL. [PMID: 25069256]
  • Jung-eun Park, Chiman Song, Keehyun Choi, Taebo Sim, Bongjin Moon, Eun Joo Roh. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors. Bioorganic & medicinal chemistry letters. 2013 Oct; 23(20):5515-8. doi: 10.1016/j.bmcl.2013.08.062. [PMID: 24012181]
  • Birger Wenge, Heinz Bönisch. The role of cysteines and histidins of the norepinephrine transporter. Neurochemical research. 2013 Jul; 38(7):1303-14. doi: 10.1007/s11064-013-1022-3. [PMID: 23525969]
  • Motoyasu Yamashita, Yasufumi Sakakibara, F Scott Hall, Yohtaro Numachi, Sumiko Yoshida, Hideaki Kobayashi, Osamu Uchiumi, George R Uhl, Yoshiyuki Kasahara, Ichiro Sora. Impaired cliff avoidance reaction in dopamine transporter knockout mice. Psychopharmacology. 2013 Jun; 227(4):741-9. doi: 10.1007/s00213-013-3009-9. [PMID: 23397052]
  • Jin Won Park, Hyun Woo Chung, Eun Jeong Lee, Kyung-Ho Jung, Jin-Young Paik, Kyung-Han Lee. α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells. Neuroscience letters. 2013 Apr; 541(?):184-9. doi: 10.1016/j.neulet.2013.02.022. [PMID: 23485735]
  • Sandra Malynn, Antonio Campos-Torres, Paul Moynagh, Jana Haase. The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Neurochemical research. 2013 Apr; 38(4):694-704. doi: 10.1007/s11064-012-0967-y. [PMID: 23338678]
  • Go Obara, Yumiko Toyohira, Hirohide Inagaki, Keita Takahashi, Takafumi Horishita, Takashi Kawasaki, Susumu Ueno, Masato Tsutsui, Takeyoshi Sata, Nobuyuki Yanagihara. Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells. Journal of pharmacological sciences. 2013; 121(2):138-47. doi: 10.1254/jphs.12164fp. [PMID: 23370666]
  • Ching-I A Wang, Nausad H Shaikh, Soumya Ramu, Richard J Lewis. A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter. Molecular pharmacology. 2012 Nov; 82(5):898-909. doi: 10.1124/mol.112.080630. [PMID: 22874414]
  • Shu-fei Lin, Xiaoning Fan, Catherine Weikart Yeckel, David Weinzimmer, Tim Mulnix, Jean-Dominique Gallezot, Richard E Carson, Robert S Sherwin, Yu-Shin Ding. Ex vivo and in vivo evaluation of the norepinephrine transporter ligand [11C]MRB for brown adipose tissue imaging. Nuclear medicine and biology. 2012 Oct; 39(7):1081-6. doi: 10.1016/j.nucmedbio.2012.04.005. [PMID: 22595487]
  • Yosefu Arime, Yoshiyuki Kasahara, F Scott Hall, George R Uhl, Ichiro Sora. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2012 Oct; 37(11):2522-30. doi: 10.1038/npp.2012.114. [PMID: 22781838]
  • Lauren P Wills, Richard E Trager, Gyda C Beeson, Christopher C Lindsey, Yuri K Peterson, Craig C Beeson, Rick G Schnellmann. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. The Journal of pharmacology and experimental therapeutics. 2012 Jul; 342(1):106-18. doi: 10.1124/jpet.112.191528. [PMID: 22490378]
  • Juan Zhen, Solav Ali, Aloke K Dutta, Maarten E A Reith. Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive. Journal of neuroscience methods. 2012 Jan; 203(1):19-27. doi: 10.1016/j.jneumeth.2011.08.044. [PMID: 21933682]
  • Liming Shao, Michael C Hewitt, Scott C Malcolm, Fengjiang Wang, Jianguo Ma, Una C Campbell, Nancy A Spicer, Sharon R Engel, Larry W Hardy, Zhi-Dong Jiang, Rudy Schreiber, Kerry L Spear, Mark A Varney. Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues. Journal of medicinal chemistry. 2011 Aug; 54(15):5283-95. doi: 10.1021/jm101312a. [PMID: 21739935]
  • Bipasha Guptaroy, Rheaclare Fraser, Aalisha Desai, Minjia Zhang, Margaret E Gnegy. Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters. Molecular pharmacology. 2011 Mar; 79(3):520-32. doi: 10.1124/mol.110.069039. [PMID: 21149640]
  • Susanna Nencetti, Maria R Mazzoni, Gabriella Ortore, Annalina Lapucci, Janette Giuntini, Elisabetta Orlandini, Irene Banti, Elisa Nuti, Antonio Lucacchini, Gino Giannaccini, Armando Rossello. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors. European journal of medicinal chemistry. 2011 Mar; 46(3):825-34. doi: 10.1016/j.ejmech.2010.12.018. [PMID: 21272963]
  • Pamela J McMillan, Sylvia S White, Allyn Franklin, J Lynne Greenup, James B Leverenz, Murray A Raskind, Patricia Szot. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. Brain research. 2011 Feb; 1373(?):240-52. doi: 10.1016/j.brainres.2010.12.015. [PMID: 21147074]
  • Tai-Xiang Xu, Qi Ma, Roger D Spealman, Wei-Dong Yao. Amphetamine modulation of long-term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant. Journal of neurochemistry. 2010 Dec; 115(6):1643-54. doi: 10.1111/j.1471-4159.2010.07073.x. [PMID: 20969573]
  • Sandra I Hope, Sabrina L Nabhen, Celeste Soria, Liliana G Bianciotti, Marcelo S Vatta. Endothelin-1 and -3 modulate the neuronal norepinephrine transporter through multiple signalling pathways in the rat posterior hypothalamus. Neurochemistry international. 2010 Oct; 57(3):306-13. doi: 10.1016/j.neuint.2010.06.009. [PMID: 20600439]
  • Prashant Mandela, Michelle Chandley, Yao-Yu Xu, Meng-Yang Zhu, Gregory A Ordway. Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles. Neurochemistry international. 2010 May; 56(6-7):760-7. doi: 10.1016/j.neuint.2010.02.011. [PMID: 20176067]
  • Yumiko Toyohira, Susumu Ueno, Masato Tsutsui, Hideaki Itoh, Norio Sakai, Naoaki Saito, Kojiro Takahashi, Nobuyuki Yanagihara. Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity. Molecular nutrition & food research. 2010 Apr; 54(4):516-24. doi: 10.1002/mnfr.200900167. [PMID: 20087855]
  • Andreas Brust, Elka Palant, Daniel E Croker, Barbara Colless, Roger Drinkwater, Brad Patterson, Christina I Schroeder, David Wilson, Carsten K Nielsen, Maree T Smith, Dianne Alewood, Paul F Alewood, Richard J Lewis. chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. Journal of medicinal chemistry. 2009 Nov; 52(22):6991-7002. doi: 10.1021/jm9003413. [PMID: 19860431]
  • Trisha L Vickrey, Barry Condron, B Jill Venton. Detection of endogenous dopamine changes in Drosophila melanogaster using fast-scan cyclic voltammetry. Analytical chemistry. 2009 Nov; 81(22):9306-13. doi: 10.1021/ac901638z. [PMID: 19842636]
  • B Meyers, M F Kritzer. In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience. 2009 Mar; 159(1):271-82. doi: 10.1016/j.neuroscience.2008.12.010. [PMID: 19138725]
  • Zaorui Zhao, Alicia M Baros, Han-Ting Zhang, M Danet S Lapiz, Corina O Bondi, David A Morilak, James M O'Donnell. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2008 Dec; 33(13):3190-200. doi: 10.1038/npp.2008.45. [PMID: 18418364]
  • Yumi Sugimoto, Yoshinobu Kajiwara, Kazufumi Hirano, Shizuo Yamada, Noriko Tagawa, Yoshiharu Kobayashi, Yoshihiro Hotta, Jun Yamada. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. European journal of pharmacology. 2008 Sep; 592(1-3):116-22. doi: 10.1016/j.ejphar.2008.07.005. [PMID: 18655786]
  • Erica A Wehrwein, Lindsay M Parker, Anna A Wright, John M Spitsbergen, Martin Novotny, Dagmar Babankova, Greg M Swain, Beth A Habecker, David L Kreulen. Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content. American journal of physiology. Regulatory, integrative and comparative physiology. 2008 Sep; 295(3):R857-63. doi: 10.1152/ajpregu.00190.2008. [PMID: 18565836]
  • Sarah Hudson, Mehrak Kiankarimi, Wendy Eccles, Yalda S Mostofi, Marc J Genicot, Wesley Dwight, Beth A Fleck, Kathleen Gogas, Warren S Wade. Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint. Bioorganic & medicinal chemistry letters. 2008 Aug; 18(16):4495-8. doi: 10.1016/j.bmcl.2008.07.050. [PMID: 18667309]
  • Jacob P R Jacobsen, Elsebet Ø Nielsen, Rene Hummel, John Paul Redrobe, Naheed Mirza, Pia Weikop. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan. Psychopharmacology. 2008 Aug; 199(2):137-50. doi: 10.1007/s00213-008-1142-7. [PMID: 18496675]
  • Dongpei Wu, Joseph Pontillo, Brett Ching, Sarah Hudson, Yinghong Gao, Beth A Fleck, Kathleen Gogas, Warren S Wade. Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI). Bioorganic & medicinal chemistry letters. 2008 Jul; 18(14):4224-7. doi: 10.1016/j.bmcl.2008.05.057. [PMID: 18550369]
  • Donald R Gehlert, Linda K Thompson, Susan K Hemrick-Luecke, Janice Shaw. Monoaminergic compensation in the neuropeptide Y deficient mouse brain. Neuropeptides. 2008 Jun; 42(3):367-75. doi: 10.1016/j.npep.2007.10.005. [PMID: 18329096]
  • Jonas N N Eildal, Jacob Andersen, Anders S Kristensen, Anne Marie Jørgensen, Benny Bang-Andersen, Morten Jørgensen, Kristian Strømgaard. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies. Journal of medicinal chemistry. 2008 May; 51(10):3045-8. doi: 10.1021/jm701602g. [PMID: 18429609]
  • Birger Wenge, Heinz Bönisch. N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter. Naunyn-Schmiedeberg's archives of pharmacology. 2008 May; 377(3):255-65. doi: 10.1007/s00210-008-0272-0. [PMID: 18357440]
  • Dagmar E Ettlinger, Daniela Häusler, Wolfgang Wadsak, Friedrich Girschele, Karoline M Sindelar, Leonhard-Key Mien, Johanna Ungersböck, Helmut Viernstein, Kurt Kletter, Robert Dudczak, Markus Mitterhauser. Metabolism and autoradiographic evaluation of [(18)F]FE@CIT: a Comparison with [(123)I]beta-CIT and [(123)I]FP-CIT. Nuclear medicine and biology. 2008 May; 35(4):475-9. doi: 10.1016/j.nucmedbio.2008.02.008. [PMID: 18482685]
  • L Song, T Kitayama, K Morita, N Morioka, T Dohi. Down-regulation of norepinephrine transporter expression on membrane surface induced by chronic administration of desipramine and the antagonism by co-administration of local anesthetics in mice. Neurochemistry international. 2008 Mar; 52(4-5):826-33. doi: 10.1016/j.neuint.2007.09.013. [PMID: 17981365]
  • Yasushi Kiyono, Taku Sugita, Masashi Ueda, Hidekazu Kawashima, Naoki Kanegawa, Yuji Kuge, Yasuhisa Fujibayashi, Hideo Saji. Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart. Nuclear medicine and biology. 2008 Feb; 35(2):213-8. doi: 10.1016/j.nucmedbio.2007.11.006. [PMID: 18312831]
  • Balagopal Lakshmi, Mei-Ping Kung, Brian Lieberman, Jun Zhao, Rikki Waterhouse, Hank F Kung. (R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters. Nuclear medicine and biology. 2008 Jan; 35(1):43-52. doi: 10.1016/j.nucmedbio.2007.08.007. [PMID: 18158942]
  • John N Mason, Darlene C Deecher, Rhonda L Richmond, Gary Stack, Paige E Mahaney, Eugene Trybulski, Richard C Winneker, Randy D Blakely. Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter. The Journal of pharmacology and experimental therapeutics. 2007 Nov; 323(2):720-9. doi: 10.1124/jpet.107.125716. [PMID: 17673606]
  • Mark J Ferris, Charles F Mactutus, Janelle M Silvers, Ulla Hasselrot, Stephane A Beaudin, Barbara J Strupp, Rosemarie M Booze. Sex mediates dopamine and adrenergic receptor expression in adult rats exposed prenatally to cocaine. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. 2007 Nov; 25(7):445-54. doi: 10.1016/j.ijdevneu.2007.08.009. [PMID: 17933484]
  • Yohtaro Numachi, Arihisa Ohara, Motoyasu Yamashita, Setsu Fukushima, Hideaki Kobayashi, Harumi Hata, Hidekazu Watanabe, F Scott Hall, Klaus-Peter Lesch, Dennis L Murphy, George R Uhl, Ichiro Sora. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. European journal of pharmacology. 2007 Oct; 572(2-3):120-8. doi: 10.1016/j.ejphar.2007.06.022. [PMID: 17673199]
  • Andrea Muck, Ralf Gilsbach, Sandra Löbbe-Werner, Michael Brüss, Heinz Bönisch. Molecular cloning and functional expression of the murine noradrenaline transporter. Naunyn-Schmiedeberg's archives of pharmacology. 2007 Oct; 376(1-2):65-71. doi: 10.1007/s00210-007-0181-7. [PMID: 17882401]
  • Paulo H C Diniz, Janice H Silva, Marcus V Gomez, Cristina Guatimosim, Renato S Gomez. Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices. Cellular and molecular neurobiology. 2007 Sep; 27(6):757-70. doi: 10.1007/s10571-007-9162-0. [PMID: 17680357]
  • Filip A Paczkowski, Iain A Sharpe, Sébastien Dutertre, Richard J Lewis. chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. The Journal of biological chemistry. 2007 Jun; 282(24):17837-44. doi: 10.1074/jbc.m610813200. [PMID: 17428804]
  • Deog-Il Kim, Howard M Deutsch, Xiaocong Ye, Margaret M Schweri. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate. Journal of medicinal chemistry. 2007 May; 50(11):2718-31. doi: 10.1021/jm061354p. [PMID: 17489581]
  • Alin J Severance, Matthew S Milak, J S Dileep Kumar, Jaya Prabhakaran, Vattoly J Majo, Norman R Simpson, Ronald L Van Heertum, Victoria Arango, J John Mann, Ramin V Parsey. In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter. European journal of nuclear medicine and molecular imaging. 2007 May; 34(5):688-693. doi: 10.1007/s00259-006-0312-2. [PMID: 17180600]
  • Sonja Sucic, Lesley J Bryan-Lluka. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants. European journal of pharmacology. 2007 Feb; 556(1-3):27-35. doi: 10.1016/j.ejphar.2006.10.058. [PMID: 17141753]
  • Motoyasu Yamashita, Setsu Fukushima, Hao-wei Shen, F Scott Hall, George R Uhl, Yohtaro Numachi, Hideaki Kobayashi, Ichiro Sora. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2006 Oct; 31(10):2132-9. doi: 10.1038/sj.npp.1301009. [PMID: 16407898]
  • Ole V Mortensen, Susan G Amara. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters. Journal of neurochemistry. 2006 Sep; 98(5):1531-40. doi: 10.1111/j.1471-4159.2006.04060.x. [PMID: 16923164]
  • Prashant Mandela, Gregory A Ordway. KCl stimulation increases norepinephrine transporter function in PC12 cells. Journal of neurochemistry. 2006 Sep; 98(5):1521-30. doi: 10.1111/j.1471-4159.2006.04062.x. [PMID: 16879714]
  • Patricia Szot, Sylvia S White, J Lynne Greenup, James B Leverenz, Elaine R Peskind, Murray A Raskind. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006 Jan; 26(2):467-78. doi: 10.1523/jneurosci.4265-05.2006. [PMID: 16407544]
  • H R Smith, T J R Beveridge, L J Porrino. Distribution of norepinephrine transporters in the non-human primate brain. Neuroscience. 2006; 138(2):703-14. doi: 10.1016/j.neuroscience.2005.11.033. [PMID: 16427744]
  • S Mata, M Urbina, E Manzano, T Ortiz, L Lima. Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression. Journal of neuroimmunology. 2005 Dec; 170(1-2):134-40. doi: 10.1016/j.jneuroim.2005.08.007. [PMID: 16242784]
  • Peter Grundt, Theresa A Kopajtic, Jonathan L Katz, Amy Hauck Newman. N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands. Bioorganic & medicinal chemistry letters. 2005 Dec; 15(24):5419-23. doi: 10.1016/j.bmcl.2005.08.111. [PMID: 16213721]
  • Heather M Haughey, Alan L Kaiser, Thomas E Johnson, Beth Bennett, James M Sikela, Nancy R Zahniser. Norepinephrine transporter: a candidate gene for initial ethanol sensitivity in inbred long-sleep and short-sleep mice. Alcoholism, clinical and experimental research. 2005 Oct; 29(10):1759-68. doi: 10.1097/01.alc.0000183009.57805.a6. [PMID: 16269905]
  • Thomas J R Beveridge, Hilary R Smith, Michael A Nader, Linda J Porrino. Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain. Psychopharmacology. 2005 Aug; 180(4):781-8. doi: 10.1007/s00213-005-2162-1. [PMID: 15739079]
  • Kuo-Shyan Lin, Yu-Shin Ding. Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboons. Bioorganic & medicinal chemistry. 2005 Aug; 13(15):4658-66. doi: 10.1016/j.bmc.2005.04.062. [PMID: 15914010]
  • Yu-Shin Ding, Kuo-Shyan Lin, Jean Logan, Helene Benveniste, Pauline Carter. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. Journal of neurochemistry. 2005 Jul; 94(2):337-51. doi: 10.1111/j.1471-4159.2005.03202.x. [PMID: 15998285]
  • Tara L Moore, Stephen P Schettler, Ronald J Killiany, James G Herndon, Jennifer I Luebke, Mark B Moss, Douglas L Rosene. Cognitive impairment in aged rhesus monkeys associated with monoamine receptors in the prefrontal cortex. Behavioural brain research. 2005 May; 160(2):208-21. doi: 10.1016/j.bbr.2004.12.003. [PMID: 15863218]
  • Subroto Ghose, Masahiro Fujita, Paul Morrison, George Uhl, Dennis L Murphy, P David Mozley, Magnus Schou, Christer Halldin, Robert Innis. Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters. Synapse (New York, N.Y.). 2005 May; 56(2):100-4. doi: 10.1002/syn.20133. [PMID: 15729740]
  • Maarten E A Reith, Lijuan C Wang, Aloke K Dutta. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity. Journal of neuroscience methods. 2005 Apr; 143(1):87-94. doi: 10.1016/j.jneumeth.2004.09.015. [PMID: 15763140]
  • Deborah C Mash, Qinjie Ouyang, Yujing Qin, John Pablo. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. Journal of neuroscience methods. 2005 Apr; 143(1):79-85. doi: 10.1016/j.jneumeth.2004.09.013. [PMID: 15763139]
  • Maggie S Burhans, Catherine Dailey, Zachary Beard, Jason Wiesinger, Laura Murray-Kolb, Byron C Jones, John L Beard. Iron deficiency: differential effects on monoamine transporters. Nutritional neuroscience. 2005 Feb; 8(1):31-8. doi: 10.1080/10284150500047070. [PMID: 15909765]
  • Débora C Hipólide, Karin M Moreira, Karen B L Barlow, Alan A Wilson, José N Nobrega, Sergio Tufik. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Progress in neuro-psychopharmacology & biological psychiatry. 2005 Feb; 29(2):297-303. doi: 10.1016/j.pnpbp.2004.11.015. [PMID: 15694238]
  • J D Sanders, H K Happe, D B Bylund, L C Murrin. Development of the norepinephrine transporter in the rat CNS. Neuroscience. 2005; 130(1):107-17. doi: 10.1016/j.neuroscience.2004.09.014. [PMID: 15561429]
  • Karen S Rommelfanger, David Weinshenker, Gary W Miller. Reduced MPTP toxicity in noradrenaline transporter knockout mice. Journal of neurochemistry. 2004 Dec; 91(5):1116-24. doi: 10.1111/j.1471-4159.2004.02785.x. [PMID: 15569255]
  • Felix Distelmaier, Philipp Wiedemann, Michael Brüss, Heinz Bönisch. Functional importance of the C-terminus of the human norepinephrine transporter. Journal of neurochemistry. 2004 Nov; 91(3):537-46. doi: 10.1111/j.1471-4159.2004.02729.x. [PMID: 15485485]
  • Hank F Kung, Suzanne Newman, Seok-Rye Choi, Shunichi Oya, Catherine Hou, Zhi-Ping Zhuang, Paul D Acton, Karl Plössl, Jeffrey Winkler, Mei-Ping Kung. 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent. Journal of medicinal chemistry. 2004 Oct; 47(21):5258-64. doi: 10.1021/jm049917p. [PMID: 15456270]
  • E Sylvester Vizi, Gabriella Zsilla, Marc G Caron, János P Kiss. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2004 Sep; 24(36):7888-94. doi: 10.1523/jneurosci.1506-04.2004. [PMID: 15356201]
  • Jason M Williams, Jeffery D Steketee. Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex. Journal of neuroscience methods. 2004 Aug; 137(2):161-5. doi: 10.1016/j.jneumeth.2004.02.022. [PMID: 15262056]
  • Saloua Benmansour, Alfonso V Altamirano, David J Jones, Teresa A Sanchez, Georgianna G Gould, Marie Christine Pardon, David A Morilak, Alan Frazer. Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biological psychiatry. 2004 Feb; 55(3):313-6. doi: 10.1016/s0006-3223(03)00676-0. [PMID: 14744474]
  • Meng-Yang Zhu, Patrick B Kyle, Arthur S Hume, Gregory A Ordway. The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function. Neurochemical research. 2004 Feb; 29(2):419-27. doi: 10.1023/b:nere.0000013747.04964.46. [PMID: 15002740]
  • F A Paczkowski, L J Bryan-Lluka. Role of proline residues in the expression and function of the human noradrenaline transporter. Journal of neurochemistry. 2004 Jan; 88(1):203-11. doi: 10.1111/j.1471-4159.2004.02149.x. [PMID: 14675164]
  • Christian A Heidbreder, Massimiliano Bianchi, Laurent P Lacroix, Stefania Faedo, Elisabetta Perdona, Rosaria Remelli, Paolo Cavanni, Francesco Crespi. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo. Synapse (New York, N.Y.). 2003 Dec; 50(4):269-76. doi: 10.1002/syn.10261. [PMID: 14556231]
  • Aurelio Orjales, Ramón Mosquera, Antonio Toledo, M Carmen Pumar, Neftalí García, Lourdes Cortizo, Luis Labeaga, Ana Innerárity. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters. Journal of medicinal chemistry. 2003 Dec; 46(25):5512-32. doi: 10.1021/jm0309349. [PMID: 14640559]
  • Yasushi Kiyono, Naoki Kanegawa, Hidekazu Kawashima, Hiromi Fujiwara, Yasuhiko Iida, Hiroshi Nishimura, Hideo Saji. A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine. Nuclear medicine and biology. 2003 Oct; 30(7):697-706. doi: 10.1016/s0969-8051(03)00085-4. [PMID: 14499327]
  • Linda Cleary, James R Docherty. Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. European journal of pharmacology. 2003 Aug; 476(1-2):31-4. doi: 10.1016/s0014-2999(03)02173-3. [PMID: 12969746]
  • Sandra Horschitz, René Hummerich, Patrick Schloss. Functional coupling of serotonin and noradrenaline transporters. Journal of neurochemistry. 2003 Aug; 86(4):958-65. doi: 10.1046/j.1471-4159.2003.01899.x. [PMID: 12887693]
  • Mark M Goodman, Ping Chen, Christophe Plisson, Laurent Martarello, James Galt, John R Votaw, Clinton D Kilts, Gene Malveaux, Vernon M Camp, Bing Shi, Timothy D Ely, Leonard Howell, Jon McConathy, Charles B Nemeroff. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. Journal of medicinal chemistry. 2003 Mar; 46(6):925-35. doi: 10.1021/jm0100180. [PMID: 12620070]
  • K T O'Leary, F M Leslie. Developmental regulation of nicotinic acetylcholine receptor-mediated [3H]norepinephrine release from rat cerebellum. Journal of neurochemistry. 2003 Mar; 84(5):952-9. doi: 10.1046/j.1471-4159.2003.01575.x. [PMID: 12603820]
  • Päivi Marjamäki, Jörg Zessin, Olli Eskola, Tove Grönroos, Merja Haaparanta, Jörgen Bergman, Pertti Lehikoinen, Sarita Forsback, Peter Brust, Jörg Steinbach, Olof Solin. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats. Synapse (New York, N.Y.). 2003 Jan; 47(1):45-53. doi: 10.1002/syn.10150. [PMID: 12422372]
  • Darrel J Macey, Hilary R Smith, Michael A Nader, Linda J Porrino. Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2003 Jan; 23(1):12-6. doi: 10.1523/jneurosci.23-01-00012.2003. [PMID: 12514195]